Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $2.71 in the prior trading day, Elevation Oncology Inc (NASDAQ: ELEV) closed at $2.70, down -0.37%. In other words, the price has decreased by -$0.37 from its previous closing price. On the day, 1.63 million shares were traded. ELEV stock price reached its highest trading level at $2.75 during the session, while it also had its lowest trading level at $2.61.
Ratios:
Our goal is to gain a better understanding of ELEV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 46.22 and its Current Ratio is at 46.22. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $10.
On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $8.
On March 01, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $7.JMP Securities initiated its Mkt Outperform rating on March 01, 2024, with a $7 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELEV now has a Market Capitalization of 148069616 and an Enterprise Value of 74281304.
Stock Price History:
The Beta on a monthly basis for ELEV is 1.39, which has changed by 0.92857146 over the last 52 weeks, in comparison to a change of 0.21656322 over the same period for the S&P500. Over the past 52 weeks, ELEV has reached a high of $5.83, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is -15.67%, while the 200-Day Moving Average is calculated to be 6.17%.
Shares Statistics:
The stock has traded on average 827.83K shares per day over the past 3-months and 1111740 shares per day over the last 10 days, according to various share statistics. A total of 54.64M shares are outstanding, with a floating share count of 44.86M. Insiders hold about 17.89% of the company’s shares, while institutions hold 79.04% stake in the company. Shares short for ELEV as of 1719532800 were 5191072 with a Short Ratio of 6.27, compared to 1717113600 on 5307669. Therefore, it implies a Short% of Shares Outstanding of 5191072 and a Short% of Float of 10.08.
